Alliancebernstein L.P. lowered its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 64.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,422 shares of the company’s stock after selling 43,342 shares during the quarter. Alliancebernstein L.P. owned about 0.05% of Azenta worth $1,171,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Schroder Investment Management Group lifted its stake in shares of Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company’s stock worth $70,183,000 after acquiring an additional 447,292 shares during the period. Norges Bank acquired a new position in shares of Azenta during the 4th quarter valued at $25,403,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company’s stock valued at $225,000 after buying an additional 576 shares during the period. Zions Bancorporation N.A. boosted its stake in Azenta by 15.8% during the fourth quarter. Zions Bancorporation N.A. now owns 27,678 shares of the company’s stock valued at $1,384,000 after buying an additional 3,774 shares in the last quarter. Finally, Segall Bryant & Hamill LLC bought a new stake in Azenta in the fourth quarter worth about $14,405,000. Institutional investors own 99.08% of the company’s stock.
Analysts Set New Price Targets
AZTA has been the topic of a number of recent analyst reports. Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday, February 6th. Evercore ISI raised their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Finally, Stephens reiterated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd.
Azenta Stock Performance
Shares of NASDAQ AZTA opened at $25.25 on Friday. The business has a 50 day simple moving average of $36.94 and a 200 day simple moving average of $43.99. Azenta, Inc. has a 52 week low of $24.68 and a 52 week high of $63.58. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of -8.47 and a beta of 1.66.
Azenta (NASDAQ:AZTA – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- How to trade penny stocks: A step-by-step guide
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Compound Interest and Why It Matters When Investing
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Investing In Preferred Stock vs. Common Stock
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.